Pfizer Inc. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pfizer Inc. with three other
companies in this sector in UNITED STATES :
Abbvie Inc
(2020
sales of $45.80 billion
of which 100%
was pharmaceutical products),
Bristol-Myers Squibb Company
($42.52 billion
of which 28%
was Prioritized Brands-Revlimid), and
Merck & Co. , Inc.
($47.99 billion
of which 90%
was Merck Pharmaceutical).
Sales Analysis.
During the year ended December of 2020, sales at
Pfizer Inc. were $41.91 billion.
This
is
a
decrease of 19.0%
versus 2019, when the company's sales were $51.75 billion.